Report Detail
Global and United States Cancer Biomarkers Market Insights, Forecast to 2026
- RnM4196337 |
- 08 September, 2020 |
- Global |
- 149 Pages |
- QYResearch |
- Chemical & Material
Cancer Biomarkers market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Cancer Biomarkers market is segmented into
Protein Biomarkers
Genetic Biomarkers
Others
Segment by Application, the Cancer Biomarkers market is segmented into
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancer
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Regional and Country-level Analysis
The Cancer Biomarkers market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Biomarkers market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Biomarkers Market Share Analysis
Cancer Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Biomarkers business, the date to enter into the Cancer Biomarkers market, Cancer Biomarkers product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Illumina,Inc.
Agilent Technologies
Qiagen NV
Merck & Co.
Hologic,Inc.
Novartis AG
BioMerieux SA
Genomic Health
Affymetrix
Roche Diagnostics Ltd.
1 Study Coverage
- 1.1 Cancer Biomarkers Product Introduction
- 1.2 Market Segments
- 1.3 Key Cancer Biomarkers Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Cancer Biomarkers Market Size Growth Rate by Type
- 1.4.2 Protein Biomarkers
- 1.4.3 Genetic Biomarkers
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Cancer Biomarkers Market Size Growth Rate by Application
- 1.5.2 Breast Cancer
- 1.5.3 Lung Cancer
- 1.5.4 Colorectal Cancer
- 1.5.5 Melanoma
- 1.5.6 Blood Cancer
- 1.5.7 Prostate Cancer
- 1.5.8 Ovarian Cancer
- 1.5.9 Stomach Cancer
- 1.5.10 Liver Cancer
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cancer Biomarkers Market Size, Estimates and Forecasts
- 2.1.1 Global Cancer Biomarkers Revenue 2015-2026
- 2.1.2 Global Cancer Biomarkers Sales 2015-2026
- 2.2 Global Cancer Biomarkers, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Cancer Biomarkers Historical Market Size by Region (2015-2020)
- 2.3.1 Global Cancer Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Cancer Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Cancer Biomarkers Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Cancer Biomarkers Sales Forecast by Region (2021-2026)
- 2.4.2 Global Cancer Biomarkers Revenue Forecast by Region (2021-2026)
3 Global Cancer Biomarkers Competitor Landscape by Players
- 3.1 Global Top Cancer Biomarkers Sales by Manufacturers
- 3.1.1 Global Cancer Biomarkers Sales by Manufacturers (2015-2020)
- 3.1.2 Global Cancer Biomarkers Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Cancer Biomarkers Manufacturers by Revenue
- 3.2.1 Global Cancer Biomarkers Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Cancer Biomarkers Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Cancer Biomarkers Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Cancer Biomarkers Revenue in 2019
- 3.2.5 Global Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Cancer Biomarkers Price by Manufacturers
- 3.4 Global Cancer Biomarkers Manufacturing Base Distribution, Product Types
- 3.4.1 Cancer Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cancer Biomarkers Product Type
- 3.4.3 Date of International Manufacturers Enter into Cancer Biomarkers Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Cancer Biomarkers Market Size by Type (2015-2020)
- 4.1.1 Global Cancer Biomarkers Sales by Type (2015-2020)
- 4.1.2 Global Cancer Biomarkers Revenue by Type (2015-2020)
- 4.1.3 Cancer Biomarkers Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Cancer Biomarkers Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Cancer Biomarkers Sales Forecast by Type (2021-2026)
- 4.2.2 Global Cancer Biomarkers Revenue Forecast by Type (2021-2026)
- 4.2.3 Cancer Biomarkers Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Cancer Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Cancer Biomarkers Market Size by Application (2015-2020)
- 5.1.1 Global Cancer Biomarkers Sales by Application (2015-2020)
- 5.1.2 Global Cancer Biomarkers Revenue by Application (2015-2020)
- 5.1.3 Cancer Biomarkers Price by Application (2015-2020)
- 5.2 Cancer Biomarkers Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Cancer Biomarkers Sales Forecast by Application (2021-2026)
- 5.2.2 Global Cancer Biomarkers Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Cancer Biomarkers Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Cancer Biomarkers Market Size YoY Growth 2015-2026
- 6.1.1 United States Cancer Biomarkers Sales YoY Growth 2015-2026
- 6.1.2 United States Cancer Biomarkers Revenue YoY Growth 2015-2026
- 6.1.3 United States Cancer Biomarkers Market Share in Global Market 2015-2026
- 6.2 United States Cancer Biomarkers Market Size by Players (International and Local Players)
- 6.2.1 United States Top Cancer Biomarkers Players by Sales (2015-2020)
- 6.2.2 United States Top Cancer Biomarkers Players by Revenue (2015-2020)
- 6.3 United States Cancer Biomarkers Historic Market Review by Type (2015-2020)
- 6.3.1 United States Cancer Biomarkers Sales Market Share by Type (2015-2020)
- 6.3.2 United States Cancer Biomarkers Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Cancer Biomarkers Price by Type (2015-2020)
- 6.4 United States Cancer Biomarkers Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Cancer Biomarkers Sales Forecast by Type (2021-2026)
- 6.4.2 United States Cancer Biomarkers Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Cancer Biomarkers Price Forecast by Type (2021-2026)
- 6.5 United States Cancer Biomarkers Historic Market Review by Application (2015-2020)
- 6.5.1 United States Cancer Biomarkers Sales Market Share by Application (2015-2020)
- 6.5.2 United States Cancer Biomarkers Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Cancer Biomarkers Price by Application (2015-2020)
- 6.6 United States Cancer Biomarkers Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Cancer Biomarkers Sales Forecast by Application (2021-2026)
- 6.6.2 United States Cancer Biomarkers Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Cancer Biomarkers Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Cancer Biomarkers Market Size YoY Growth 2015-2026
- 7.2 North America Cancer Biomarkers Market Facts & Figures by Country
- 7.2.1 North America Cancer Biomarkers Sales by Country (2015-2020)
- 7.2.2 North America Cancer Biomarkers Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Cancer Biomarkers Market Size YoY Growth 2015-2026
- 8.2 Europe Cancer Biomarkers Market Facts & Figures by Country
- 8.2.1 Europe Cancer Biomarkers Sales by Country
- 8.2.2 Europe Cancer Biomarkers Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Cancer Biomarkers Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Cancer Biomarkers Market Facts & Figures by Country
- 9.2.1 Asia Pacific Cancer Biomarkers Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Cancer Biomarkers Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Cancer Biomarkers Market Size YoY Growth 2015-2026
- 10.2 Latin America Cancer Biomarkers Market Facts & Figures by Country
- 10.2.1 Latin America Cancer Biomarkers Sales by Country
- 10.2.2 Latin America Cancer Biomarkers Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Cancer Biomarkers Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Cancer Biomarkers Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Cancer Biomarkers Sales by Country
- 11.2.2 Middle East and Africa Cancer Biomarkers Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Corporation Information
- 12.1.2 Abbott Laboratories Description and Business Overview
- 12.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Abbott Laboratories Cancer Biomarkers Products Offered
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Corporation Information
- 12.2.2 Thermo Fisher Scientific Description and Business Overview
- 12.2.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Thermo Fisher Scientific Cancer Biomarkers Products Offered
- 12.2.5 Thermo Fisher Scientific Recent Development
- 12.3 F. Hoffmann-La Roche Ltd
- 12.3.1 F. Hoffmann-La Roche Ltd Corporation Information
- 12.3.2 F. Hoffmann-La Roche Ltd Description and Business Overview
- 12.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 F. Hoffmann-La Roche Ltd Cancer Biomarkers Products Offered
- 12.3.5 F. Hoffmann-La Roche Ltd Recent Development
- 12.4 Illumina,Inc.
- 12.4.1 Illumina,Inc. Corporation Information
- 12.4.2 Illumina,Inc. Description and Business Overview
- 12.4.3 Illumina,Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Illumina,Inc. Cancer Biomarkers Products Offered
- 12.4.5 Illumina,Inc. Recent Development
- 12.5 Agilent Technologies
- 12.5.1 Agilent Technologies Corporation Information
- 12.5.2 Agilent Technologies Description and Business Overview
- 12.5.3 Agilent Technologies Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Agilent Technologies Cancer Biomarkers Products Offered
- 12.5.5 Agilent Technologies Recent Development
- 12.6 Qiagen NV
- 12.6.1 Qiagen NV Corporation Information
- 12.6.2 Qiagen NV Description and Business Overview
- 12.6.3 Qiagen NV Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Qiagen NV Cancer Biomarkers Products Offered
- 12.6.5 Qiagen NV Recent Development
- 12.7 Merck & Co.
- 12.7.1 Merck & Co. Corporation Information
- 12.7.2 Merck & Co. Description and Business Overview
- 12.7.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Merck & Co. Cancer Biomarkers Products Offered
- 12.7.5 Merck & Co. Recent Development
- 12.8 Hologic,Inc.
- 12.8.1 Hologic,Inc. Corporation Information
- 12.8.2 Hologic,Inc. Description and Business Overview
- 12.8.3 Hologic,Inc. Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Hologic,Inc. Cancer Biomarkers Products Offered
- 12.8.5 Hologic,Inc. Recent Development
- 12.9 Novartis AG
- 12.9.1 Novartis AG Corporation Information
- 12.9.2 Novartis AG Description and Business Overview
- 12.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Novartis AG Cancer Biomarkers Products Offered
- 12.9.5 Novartis AG Recent Development
- 12.10 BioMerieux SA
- 12.10.1 BioMerieux SA Corporation Information
- 12.10.2 BioMerieux SA Description and Business Overview
- 12.10.3 BioMerieux SA Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 BioMerieux SA Cancer Biomarkers Products Offered
- 12.10.5 BioMerieux SA Recent Development
- 12.11 Abbott Laboratories
- 12.11.1 Abbott Laboratories Corporation Information
- 12.11.2 Abbott Laboratories Description and Business Overview
- 12.11.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Abbott Laboratories Cancer Biomarkers Products Offered
- 12.11.5 Abbott Laboratories Recent Development
- 12.12 Affymetrix
- 12.12.1 Affymetrix Corporation Information
- 12.12.2 Affymetrix Description and Business Overview
- 12.12.3 Affymetrix Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 Affymetrix Products Offered
- 12.12.5 Affymetrix Recent Development
- 12.13 Roche Diagnostics Ltd.
- 12.13.1 Roche Diagnostics Ltd. Corporation Information
- 12.13.2 Roche Diagnostics Ltd. Description and Business Overview
- 12.13.3 Roche Diagnostics Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Roche Diagnostics Ltd. Products Offered
- 12.13.5 Roche Diagnostics Ltd. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Cancer Biomarkers Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cancer Biomarkers Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Biomarkers. Industry analysis & Market Report on Cancer Biomarkers is a syndicated market report, published as Global and United States Cancer Biomarkers Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Cancer Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
